Library / Laws / 116th Congress / House Bills / H.R. 965
H.R. 965
To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-02-05 | 20.3K | ⠃⠗⠋ |
| Reported in House | 2019-02-05 | 19.0K | ⠃⠗⠋ |